Agios Pharmaceuticals, Inc. (0HB0.L)
USD 41.74
(-0.05%)
USD 41.74
(-0.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -296.06 Million | -309.47 Million | -407.32 Million | -290.75 Million | -370.62 Million | -304.42 Million |
| Net Income | -352.08 Million | -231.8 Million | -356.51 Million | -329.3 Million | -411.47 Million | -346.02 Million |
| Depreciation & Amortization | 6.62 Million | 18.55 Million | 18.77 Million | 18.77 Million | 16.61 Million | 7.17 Million |
| Deferred income taxes | -77.93 Million | -38.59 Million | -93.57 Million | -103.18 Million | -98.91 Million | -65.71 Million |
| Stock-based compensation | 44.76 Million | 49.29 Million | 53.5 Million | 61.6 Million | 58.05 Million | 73.35 Million |
| Change in working capital | -10.32 Million | -16.43 Million | -36.82 Million | 1.96 Million | -45.99 Million | -35.1 Million |
| Other non-cash items | 14.96 Million | -35.87 Million | 7.3 Million | 59.39 Million | 111.09 Million | 96.14 Million |
| Investing Cash Flow | 239.57 Million | 243.26 Million | 1.24 Billion | 75.74 Million | 91.44 Million | -273.82 Million |
| Investments in PPE | -999 Thousand | -4.88 Million | -5.74 Million | -14.1 Million | -12.17 Million | -6.98 Million |
| Acquisitions | 1.32 Million | 132.74 Million | - | - | -103.46 Million | - |
| Investment purchases | -417.93 Million | -1.03 Billion | -1.37 Billion | -557.03 Million | -488.56 Million | -933.32 Million |
| Sales/Maturities of investments | 674.67 Million | 1.14 Billion | 829.8 Million | 647.68 Million | 592.17 Million | 666.48 Million |
| Other Investing Activities | 240.57 Million | 248.14 Million | 1.8 Billion | -803 Thousand | 103.46 Million | -266.83 Million |
| Financing Cash Flow | 5.43 Million | 2.35 Million | -765.76 Million | 261.51 Million | 289.61 Million | 546.02 Million |
| Debt repayment | - | -331 Thousand | -578 Thousand | -336 Thousand | -113 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -802.48 Million | - | - | - |
| Common Stock Issuance | 5.43 Million | 2.68 Million | 37.29 Million | 11.31 Million | 289.72 Million | 546.02 Million |
| Other Financing Activities | 5.43 Million | 2.68 Million | 37.29 Million | 250.53 Million | 289.72 Million | 546.02 Million |
| Accounts receivables | -604 Thousand | -1.75 Million | -4.37 Million | 7.36 Million | -4.87 Million | -6.77 Million |
| Accounts payables | -8.73 Million | 3.43 Million | 1.86 Million | 3.33 Million | 3.71 Million | -5.48 Million |
| Inventory | -10.58 Million | -8.49 Million | - | -7.36 Million | -6.46 Million | -869 Thousand |
| Other working capital | 864 Thousand | -9.61 Million | -34.3 Million | -1.36 Million | -38.37 Million | -22.84 Million |
| Cash at beginning of period | 139.25 Million | 203.12 Million | 127.43 Million | 80.93 Million | 70.5 Million | 102.72 Million |
| Cash at end of period | 88.2 Million | 139.25 Million | 203.12 Million | 127.43 Million | 80.93 Million | 70.5 Million |
| Capital Expenditure | -999 Thousand | -4.88 Million | -5.74 Million | -14.1 Million | -12.17 Million | -6.98 Million |
| Effect of forex changes on cash | - | - | - | 1.00 | - | - |
| Net cash flow / Change in cash | -51.05 Million | -63.86 Million | 75.69 Million | 46.5 Million | 10.42 Million | -32.22 Million |
| Free Cash Flow | -297.06 Million | -314.35 Million | -413.06 Million | -304.86 Million | -382.79 Million | -311.4 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 947.91 Million | -96.11 Million | -81.54 Million | -352.08 Million | -95.94 Million | -91.32 Million |
| Depreciation & Amortization | 1.34 Million | 1.59 Million | 1.34 Million | 6.62 Million | 1.4 Million | 1.62 Million |
| Deferred income taxes | - | - | - | -77.93 Million | -23.58 Million | -8.54 Million |
| Stock-based compensation | - | 11.56 Million | 9.23 Million | 44.76 Million | 13.81 Million | 9.07 Million |
| Change in working capital | 45.35 Million | 11.28 Million | -28.98 Million | -19.05 Million | 5.6 Million | -2.7 Million |
| Other non-cash items | -1.07 Billion | -916 Thousand | 15.22 Million | 101.62 Million | 26.22 Million | 32.89 Million |
| Investing Cash Flow | 250.79 Million | 37.24 Million | 124.56 Million | 239.57 Million | 95.51 Million | 39.34 Million |
| Investments in PPE | -419 Thousand | -158 Thousand | -141 Thousand | -999 Thousand | -234 Thousand | -369 Thousand |
| Acquisitions | - | - | 40 Thousand | 1.32 Million | -95.74 Million | 1.17 Million |
| Investment purchases | -995.5 Million | -104.54 Million | -244.05 Million | -417.93 Million | -90.44 Million | -95 Million |
| Sales/Maturities of investments | 157.57 Million | 141.94 Million | 368.72 Million | 674.67 Million | 186.18 Million | 151.03 Million |
| Other Investing Activities | 1.08 Billion | 37.4 Million | 124.7 Million | -17.5 Million | 95.74 Million | -17.5 Million |
| Financing Cash Flow | 2.63 Million | 1.09 Million | 5.86 Million | 5.43 Million | 847 Thousand | 1.88 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.63 Million | 1.09 Million | 5.86 Million | 5.43 Million | 847 Thousand | 1.88 Million |
| Other Financing Activities | - | 1.09 Million | 5.86 Million | 5.43 Million | 847 Thousand | 1.88 Million |
| Accounts receivables | 644 Thousand | -309 Thousand | -643 Thousand | -604 Thousand | -1.63 Million | 1.07 Million |
| Accounts payables | 7.08 Million | -1.16 Million | 1.43 Million | -8.73 Million | -3.53 Million | 1.63 Million |
| Inventory | -2.49 Million | -867 Thousand | -3.99 Million | -10.58 Million | -1.8 Million | -1.6 Million |
| Other working capital | 40.11 Million | 12.46 Million | -25.77 Million | 864 Thousand | 12.56 Million | -3.81 Million |
| Cash at beginning of period | 84.51 Million | 118.76 Million | 88.2 Million | 139.25 Million | 64.33 Million | 84.75 Million |
| Cash at end of period | 253.73 Million | 84.51 Million | 118.76 Million | 88.2 Million | 88.2 Million | 64.33 Million |
| Capital Expenditure | -419 Thousand | -158 Thousand | -141 Thousand | -999 Thousand | -234 Thousand | -369 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 169.21 Million | -34.24 Million | 30.55 Million | -51.05 Million | 23.87 Million | -20.42 Million |
| Free Cash Flow | -84.63 Million | -72.74 Million | -100 Million | -297.06 Million | -72.72 Million | -62.01 Million |
HDF
3OY1
BLK
FYNBK
CLF
SUI